Protective effect of Macleaya cordata isoquinoline alkaloids on lipopolysaccharide-induced liver injury in broilers
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: This experiment aimed to explore the protective action of dietary supplementation with isoquinoline alkaloids (IA) from <i>Macleaya cordata</i> on lipopolysaccharide (LPS)-induced liver injury in broilers.Methods: Total 216 healthy broilers were selected in a 21-d trial and assigned randomly to the following 3 treatments: control (CON) group, LPS group, and LPS+IA group. The CON and LPS groups were provided with a basal diet, whereas the LPS+IA group received the basal diet supplemented with 0.6 mg/kg <i>Macleaya cordata</i> IA. Broilers in LPS and LPS+IA groups were intraperitoneally injected with LPS (1 mg/kg body weight) at 17, 19, and 21 days of age, while those in CON group were injected with equivalent amount of saline solution.Results: Results showed LPS injection caused systemic and liver inflammation in broilers, inhibited immune function, and ultimately lead to liver injury. By contrast, supplementation of IA ameliorated LPS-induced adverse change in serum parameters, boosted immunity in LPS+IA group. Furthermore, IA suppressed the elevation of hepatic inflammatory cytokines and caspases levels induced by LPS, as well as the expressions of genes related to the tolllike receptor 4 (TLR4)/myeloid differentiation primary response 88 (MyD88)/nuclear factorkappa B (NF-κB) pathway.Conclusion: Dietary inclusion of 0.6 mg/kg <i>Macleaya cordata</i> IA could enhance immune function of body and inhibit liver damage via inactivating TLR4/MyD88/NF-κB signaling pathway in broilers.
Abstract
Objective: This experiment aimed to explore the protective action of dietary supplementation with isoquinoline alkaloids (IA) from Macleaya cordata on lipopolysaccharide (LPS)-induced liver injury in broilers. Methods: Total 216 healthy broilers were selected in a 21-d trial and assigned randomly to the following 3 treatments: control (CON) group, LPS group, and LPS+IA group. The CON and LPS groups were provided with a basal diet, whereas the LPS+IA group received the basal diet supplemented with 0.6 mg/kg Macleaya cordata IA. Broilers in LPS and LPS+IA groups were intraperitoneally injected with LPS (1 mg/kg body weight) at 17, 19, and 21 days of age, while those in CON group were injected with equivalent amount of saline solution. Results: Results showed LPS injection caused systemic and liver inflammation in broilers, inhibited immune function, and ultimately lead to liver injury. By contrast, supplementation of IA ameliorated LPS-induced adverse change in serum parameters, boosted immunity in LPS+IA group. Furthermore, IA suppressed the elevation of hepatic inflammatory cytokines and caspases levels induced by LPS, as well as the expressions of genes related to the tolllike receptor 4 (TLR4)/myeloid differentiation primary response 88 (MyD88)/nuclear factorkappa B (NF-κB) pathway. Conclusion: Dietary inclusion of 0.6 mg/kg Macleaya cordata IA could enhance immune function of body and inhibit liver damage via inactivating TLR4/MyD88/NF-κB signaling pathway in broilers.
참고문헌 (54)
- Racanelli V, "The liver as an immunological organ", Hepatology, 43, pp.S54~S62 (2006)[DOI]
- Wang Q, "Supplementation of paraformic acid as a substitute for antibiotics in the diet improves growth performance and liver health in broiler chickens", Animals(Basel), 12, pp.2825~ (2022)[DOI]
- Almazroo OA, "Drug metabolism in the liver", Clin Liver Dis, 21, pp.1~20 (2017)[DOI]
- Mei W, "Hepatic Inflammatory response to exogenous LPS challenge is exacerbated in broilers with fatty liver disease", Animals(Basel), 10, pp.514~ (2020)[DOI]
- Adachi Y, "Antibiotics prevent liver injury in rats following long-term exposure to ethanol", Gastroenterology, 108, pp.218~224 (1995)[DOI]
- Singer RS, "Antibiotic resistance-the interplay between antibiotic use in animals and human beings", Lancet Infect Dis, 3, pp.47~51 (2003)[DOI]
- Liu Y, "Effects of dietary Macleaya cordata extract containing isoquinoline alkaloids supplementation as an alternative to antibiotics in the diets on growth performance and liver health of broiler chickens", Front Vet Sci, 9, pp.950174~ (2022)[DOI]
- Kosina P, "Phytochemical and antimicrobial characterization of Macleaya cordata herb", Fitoterapia, 81, pp.1006~1012 (2010)[DOI]
- Ni H, "Analysis of the impact of isoquinoline alkaloids, derived from Macleaya cordata extract, on the development and innate immune response in swine and poultry", Biomed Res Int, 2016, pp.1352146~ (2016)[DOI]
- Kantas D, "The effect of a natural feed additive(Macleaya cordata), containing sanguinarine, on the performance and health status of weaning pigs", Anim Sci J, 86, pp.92~98 (2015)[DOI]
- Guo S, "Effects of Macleaya cordata extract on laying performance, egg quality, and serum indices in Xuefeng black-bone chicken", Poult Sci, 100, pp.101031~ (2021)[DOI]
- Liu H, "Effects of dietary Bopu powder supplementation on serum antioxidant capacity, egg quality, and intestinal microbiota of laying hens", Front Physiol, 13, pp.902784~ (2022)[DOI]
- Liu Y, "Effects of dietary Bopu powder supplementation on intestinal development and microbiota in broiler chickens", Front Microbiol, 13, pp.1019130~ (2022)[DOI]
- Li Y, "Effects of dietary supplementation with exogenous catalase on growth performance, oxidative stress, and hepatic apoptosis in weaned piglets challenged with lipopolysaccharide", J Anim Sci, 98, pp.skaa067~ (2020)[DOI]
- Qu J, "Inhibition of Lipopolysaccharide-induced inflammation of chicken liver tissue by selenomethionine via TLR4-NF-κB-NLRP3 signaling pathway", Biol Trace Elem Res, 195, pp.205~214 (2020)[DOI]
- Huang XY, "Lipopolysaccharide mediates immuno-pathological alterations in young chicken liver through TLR4 signaling", BMC Immunol, 18, pp.12~ (2017)[DOI]
- Jiang J, "Dietary stevioside supplementation alleviates lipopolysaccharide-induced intestinal mucosal damage through anti-inflammatory and antioxidant effects in broiler chickens", Antioxidants(Basel), 8, pp.575~ (2019)[DOI]
- Takahashi K, "Effect of dietary supplementation of astaxanthin from Phaffia rhodozyma on lipopolysaccharide-induced early inflammatory responses in male broiler chickens(Gallus gallus)fed a corn-enriched diet", Anim Sci J, 82, pp.753~758 (2011)[DOI]
- Chen J, "Comparison of gut microbiota and metabolic status of sows with different litter sizes during pregnancy", Front Vet Sci, 8, pp.793174~ (2021)[DOI]
- Chen J, "Supplementation with exogenous catalase from Penicillium notatum in the diet ameliorates Lipopolysaccharide-induced intestinal oxidative damage through affecting intestinal antioxidant capacity and microbiota in weaned pigs", Microbiol Spectr, 9, pp.e00654-21~ (2021)[DOI]
- Schmittgen TD, "Analyzing real-time PCR data by the comparative C(T)method", Nat Protoc, 3, pp.1101~1108 (2008)[DOI]
- Kim WR, "Serum activity of alanine aminotransferase(ALT)as an indicator of health and disease", Hepatology, 47, pp.1363~1370 (2008)[DOI]
- Senior JR, "Alanine aminotransferase : a clinical and regulatory tool for detecting liver injury–past, present, and future", Clin Pharmacol Ther, 92, pp.332~339 (2012)[DOI]
- Delanghe JR, "Complement C3 and its polymorphism : biological and clinical consequences", Pathology, 46, pp.1~10 (2014)[DOI]
- Qin X, "The complement system in liver diseases", Cell Mol Immunol, 3, pp.333~340 (2006)
- Thorgersen EB, "The role of complement in liver injury, regeneration, and transplantation", Hepatology, 70, pp.725~736 (2019)[DOI]
- Zhang QY, "Salvianolic acid A alleviates lipopolysaccharide-induced disseminated intravascular coagulation by inhibiting complement activation", BMC Complement Med Ther, 22, pp.245~ (2022)[DOI]
- Li MF, "An overview of complement systems in teleosts", Dev Comp Immunol, 137, pp.104520~ (2022)[DOI]
- Lin C, "Complement inhibition alleviates donor brain death-induced liver injury and posttransplant cascade injury by regulating phosphoinositide 3-kinase signaling", Am J Transplant, 23, pp.484~497 (2023)[DOI]
- Bell CC, "Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease", Sci Rep, 6, pp.25187~ (2016)[DOI]
- Korhonen H, "Milk immunoglobulins and complement factors", Br J Nutr, 84(Suppl 1), pp.S75~S80 (2000)[DOI]
- Liu J, "Role of the IgM Fc receptor in immunity and tolerance", Front Immunol, 10, pp.529~ (2019)[DOI]
- Aschermann S, "The other side of immunoglobulin G : suppressor of inflammation", Clin Exp Immunol, 160, pp.161~167 (2010)[DOI]
- Isho B, "Fantastic IgA plasma cells and where to find them", Immunol Rev, 303, pp.119~137 (2021)[DOI]
- Umaya SR, "Exploration of plant products and phytochemicals against aflatoxin toxicity in broiler chicken production : Present status", Toxicon, 200, pp.55~68 (2021)[DOI]
- Barter P, "HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events", N Engl J Med, 357, pp.1301~1310 (2007)[DOI]
- Wolf D, "Immunity and inflammation in atherosclerosis", Circ Res, 124, pp.315~327 (2019)[DOI]
- Lopez-Castejon G, "Understanding the mechanism of IL-1β secretion", Cytokine Growth Factor Rev, 22, pp.189~195 (2011)[DOI]
- King GL, "The role of inflammatory cytokines in diabetes and its complications", J Periodontol, 79, pp.1527~1534 (2008)[DOI]
- Ding WX, "Dissection of the multiple mechanisms of TNF-alpha-induced apoptosis in liver injury", J Cell Mol Med, 8, pp.445~454 (2004)[DOI]
- Esmailbeig M, "Interleukin-18 : a regulator of cancer and autoimmune diseases", Eur Cytokine Netw, 28, pp.127~140 (2017)[DOI]
- Wallenius V, "Retarded liver growth in interleukin-6-deficient and tumor necrosis factor receptor-1-deficient mice", Endocrinology, 142, pp.2953~2960 (2001)[DOI]
- Liu X, "Remifentanil ameliorates liver ischemiareperfusion injury through inhibition of interleukin-18signaling", Transplantation, 99, pp.2109~2117 (2015)[DOI]
- Kumar R, "The role of IL-10 in malaria : a double edged sword", Front Immunol, 10, pp.229~ (2019)[DOI]
- Treffkorn L, "PGE2 exerts its effect on the LPS-induced release of TNF-alpha, ET-1, IL-1alpha, IL-6 and IL-10 via the EP2 and EP4 receptor in rat liver macrophages", Prostaglandins Other Lipid Mediat, 74, pp.113~123 (2004)[DOI]
- Jndoyan ZT, "Correlations between indicators of interleukin-10 and interleukin-6 in patients with periodic disease", Ter Arkh, 90, pp.38~41 (2018)[DOI]
- Kuzmich NN, "TLR4 signaling pathway modulators as potential therapeutics in inflammation and sepsis", Vaccines(Basel), 5, pp.34~ (2017)[DOI]
- Kong F, "Atorvastatin suppresses NLRP3 inflammasome activation via TLR4", MyD88, Biomed Pharmacother, pp.2016, 82[DOI]
- Blevins HM, "The NLRP3 inflammasome pathway : A review of mechanisms and inhibitors for the treatment of inflammatory diseases", Front Aging Neurosci, 14, pp.879021~ (2022)[DOI]
- Bai B, "NLRP3 inflammasome in endothelial dysfunction", Cell Death Dis, 11, pp.776~ (2020)[DOI]
- Lalier L, "Bax activation and mitochondrial insertion during apoptosis", Apoptosis, 12, pp.887~896 (2007)[DOI]
- Tsujimoto Y, "Role of Bcl-2 family proteins in apoptosis : apoptosomes or mitochondria?", Genes Cells, 3, pp.697~707 (1998)[DOI]
- Wu M, "Activation of pyroptosis by membrane-anchoring AIE photosensitizer design : New prospect for photodynamic cancer cell ablation", Angew Chem Int Ed, 60, pp.9093~9098 (2021)[DOI]
- Lei Q, "Biosensors for Caspase-3 : From chemical methodologies to biomedical applications", Talanta, 240, pp.123198~ (2022)[DOI]
